Alberto Serrano-Pozo, M.D., Ph.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Alzheimer Disease | 38 | 2023 | 7560 | 3.650 |
Why?
|
| Plaque, Amyloid | 18 | 2023 | 702 | 3.110 |
Why?
|
| Astrocytes | 12 | 2022 | 1243 | 2.090 |
Why?
|
| Microglia | 8 | 2022 | 1211 | 1.580 |
Why?
|
| Neurofibrillary Tangles | 8 | 2020 | 423 | 1.400 |
Why?
|
| Apolipoprotein E2 | 3 | 2021 | 126 | 1.320 |
Why?
|
| Apolipoprotein E4 | 5 | 2021 | 633 | 1.290 |
Why?
|
| Amyloid beta-Peptides | 15 | 2023 | 3388 | 1.060 |
Why?
|
| Receptors, GABA | 2 | 2022 | 257 | 0.810 |
Why?
|
| Apolipoproteins E | 4 | 2021 | 1433 | 0.800 |
Why?
|
| Brain | 21 | 2023 | 25743 | 0.670 |
Why?
|
| Gliosis | 3 | 2021 | 236 | 0.660 |
Why?
|
| Aspartic Acid Endopeptidases | 2 | 2017 | 311 | 0.640 |
Why?
|
| Nerve Degeneration | 2 | 2020 | 765 | 0.630 |
Why?
|
| PubMed | 1 | 2017 | 120 | 0.570 |
Why?
|
| Amyloid Precursor Protein Secretases | 2 | 2017 | 580 | 0.550 |
Why?
|
| Amyloid beta-Protein Precursor | 4 | 2015 | 1106 | 0.540 |
Why?
|
| tau Proteins | 7 | 2020 | 1751 | 0.540 |
Why?
|
| Disease Progression | 4 | 2021 | 13161 | 0.490 |
Why?
|
| Neurites | 3 | 2015 | 380 | 0.460 |
Why?
|
| Bibliometrics | 1 | 2017 | 331 | 0.460 |
Why?
|
| Cognition Disorders | 3 | 2016 | 4011 | 0.410 |
Why?
|
| Apolipoprotein E3 | 4 | 2021 | 89 | 0.390 |
Why?
|
| Immunohistochemistry | 9 | 2023 | 11486 | 0.370 |
Why?
|
| Amyloidosis | 1 | 2016 | 750 | 0.360 |
Why?
|
| Autopsy | 4 | 2019 | 1003 | 0.340 |
Why?
|
| Temporal Lobe | 2 | 2015 | 1656 | 0.340 |
Why?
|
| Genotype | 3 | 2021 | 12882 | 0.330 |
Why?
|
| Neurons | 7 | 2020 | 9342 | 0.310 |
Why?
|
| Simvastatin | 1 | 2010 | 358 | 0.310 |
Why?
|
| Red Nucleus | 1 | 2007 | 10 | 0.310 |
Why?
|
| Glial Fibrillary Acidic Protein | 3 | 2020 | 526 | 0.300 |
Why?
|
| Brain Stem Infarctions | 1 | 2007 | 32 | 0.300 |
Why?
|
| Neuroglia | 3 | 2023 | 923 | 0.290 |
Why?
|
| Vertebral Artery | 1 | 2005 | 186 | 0.250 |
Why?
|
| Leprosy | 1 | 2004 | 126 | 0.250 |
Why?
|
| Aged, 80 and over | 15 | 2021 | 57615 | 0.250 |
Why?
|
| Infarction | 1 | 2005 | 226 | 0.250 |
Why?
|
| Synapses | 4 | 2014 | 1721 | 0.240 |
Why?
|
| Embolism | 1 | 2007 | 401 | 0.240 |
Why?
|
| Lewy Body Disease | 3 | 2020 | 216 | 0.230 |
Why?
|
| Polyneuropathies | 1 | 2004 | 135 | 0.230 |
Why?
|
| Aged | 21 | 2023 | 161379 | 0.220 |
Why?
|
| Transcription, Genetic | 1 | 2017 | 7819 | 0.220 |
Why?
|
| Longitudinal Studies | 4 | 2021 | 13692 | 0.220 |
Why?
|
| Paraffin Embedding | 1 | 2023 | 307 | 0.210 |
Why?
|
| Neurodegenerative Diseases | 2 | 2020 | 1013 | 0.210 |
Why?
|
| Tauopathies | 2 | 2015 | 294 | 0.200 |
Why?
|
| Formaldehyde | 1 | 2023 | 358 | 0.200 |
Why?
|
| Cholesterol | 1 | 2010 | 2868 | 0.200 |
Why?
|
| Mitochondria | 3 | 2021 | 3580 | 0.200 |
Why?
|
| Cerebral Amyloid Angiopathy | 2 | 2023 | 825 | 0.200 |
Why?
|
| Biomedical Research | 1 | 2017 | 3281 | 0.200 |
Why?
|
| Humans | 45 | 2023 | 725001 | 0.190 |
Why?
|
| Spinal Diseases | 1 | 2005 | 536 | 0.190 |
Why?
|
| Hippocampus | 3 | 2021 | 3604 | 0.190 |
Why?
|
| Hypoxia-Inducible Factor 1 | 1 | 2021 | 202 | 0.190 |
Why?
|
| Aging | 6 | 2021 | 8531 | 0.180 |
Why?
|
| Peripheral Nervous System Diseases | 1 | 2004 | 701 | 0.170 |
Why?
|
| Spine | 1 | 2005 | 1108 | 0.160 |
Why?
|
| Amyloid | 2 | 2015 | 754 | 0.160 |
Why?
|
| Cell Hypoxia | 1 | 2021 | 680 | 0.160 |
Why?
|
| Male | 25 | 2023 | 346964 | 0.160 |
Why?
|
| Vaccination | 1 | 2010 | 3121 | 0.160 |
Why?
|
| Alleles | 2 | 2021 | 6940 | 0.150 |
Why?
|
| Cohort Studies | 5 | 2021 | 39883 | 0.150 |
Why?
|
| Female | 23 | 2023 | 375303 | 0.140 |
Why?
|
| Mice | 12 | 2021 | 80318 | 0.130 |
Why?
|
| Mice, Transgenic | 6 | 2017 | 9792 | 0.120 |
Why?
|
| Animals | 15 | 2021 | 168735 | 0.120 |
Why?
|
| Mental Status Schedule | 1 | 2014 | 321 | 0.120 |
Why?
|
| Adaptor Proteins, Vesicular Transport | 1 | 2015 | 317 | 0.120 |
Why?
|
| Hypoxia-Inducible Factor 1, alpha Subunit | 1 | 2017 | 625 | 0.110 |
Why?
|
| Presenilin-1 | 2 | 2015 | 627 | 0.110 |
Why?
|
| Protein Interaction Domains and Motifs | 1 | 2015 | 483 | 0.110 |
Why?
|
| Spinal Cord | 1 | 2021 | 1810 | 0.110 |
Why?
|
| Phenotype | 3 | 2023 | 16262 | 0.110 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 2 | 2017 | 3877 | 0.110 |
Why?
|
| Coronary Disease | 1 | 2007 | 6082 | 0.100 |
Why?
|
| Cell Count | 2 | 2013 | 1871 | 0.100 |
Why?
|
| Inflammation Mediators | 1 | 2020 | 1891 | 0.100 |
Why?
|
| Tomography | 1 | 2013 | 376 | 0.100 |
Why?
|
| Hydroxycholesterols | 1 | 2010 | 25 | 0.100 |
Why?
|
| Neuropsychological Tests | 2 | 2013 | 6878 | 0.100 |
Why?
|
| Protein Folding | 2 | 2014 | 845 | 0.100 |
Why?
|
| Age of Onset | 2 | 2020 | 3259 | 0.100 |
Why?
|
| Endothelial Cells | 2 | 2023 | 3377 | 0.100 |
Why?
|
| Gene Expression | 3 | 2019 | 7821 | 0.090 |
Why?
|
| Voltage-Dependent Anion Channel 1 | 1 | 2010 | 33 | 0.090 |
Why?
|
| Transduction, Genetic | 1 | 2013 | 922 | 0.090 |
Why?
|
| Positron-Emission Tomography | 2 | 2019 | 6180 | 0.090 |
Why?
|
| Phosphorylation | 4 | 2020 | 8492 | 0.090 |
Why?
|
| Energy Metabolism | 1 | 2020 | 2933 | 0.090 |
Why?
|
| alpha-Synuclein | 1 | 2015 | 686 | 0.090 |
Why?
|
| Computational Biology | 1 | 2021 | 3522 | 0.090 |
Why?
|
| Dementia | 1 | 2022 | 2378 | 0.080 |
Why?
|
| Atrophy | 1 | 2013 | 1511 | 0.080 |
Why?
|
| Histocompatibility Antigens Class II | 1 | 2013 | 1473 | 0.080 |
Why?
|
| Proteomics | 1 | 2021 | 3446 | 0.080 |
Why?
|
| Dependovirus | 1 | 2013 | 718 | 0.080 |
Why?
|
| Middle Aged | 9 | 2020 | 212155 | 0.080 |
Why?
|
| Polyradiculoneuropathy | 1 | 2007 | 66 | 0.080 |
Why?
|
| Neocortex | 1 | 2011 | 396 | 0.080 |
Why?
|
| Ubiquitin | 1 | 2012 | 850 | 0.080 |
Why?
|
| Microscopy, Confocal | 1 | 2013 | 1988 | 0.070 |
Why?
|
| Calcium | 1 | 2020 | 5758 | 0.070 |
Why?
|
| Resilience, Psychological | 1 | 2013 | 607 | 0.070 |
Why?
|
| Mice, Inbred C57BL | 4 | 2020 | 22139 | 0.070 |
Why?
|
| Magnetic Resonance Imaging | 3 | 2011 | 34755 | 0.070 |
Why?
|
| Membrane Potential, Mitochondrial | 2 | 2020 | 304 | 0.070 |
Why?
|
| Proteasome Endopeptidase Complex | 1 | 2012 | 1321 | 0.070 |
Why?
|
| Guillain-Barre Syndrome | 1 | 2007 | 134 | 0.070 |
Why?
|
| Cognition | 3 | 2022 | 6424 | 0.070 |
Why?
|
| Vincristine | 1 | 2007 | 1049 | 0.070 |
Why?
|
| Sural Nerve | 1 | 2004 | 111 | 0.060 |
Why?
|
| Myocardial Infarction | 1 | 2005 | 11531 | 0.060 |
Why?
|
| Diagnosis, Differential | 5 | 2015 | 12937 | 0.060 |
Why?
|
| Gene Expression Profiling | 1 | 2020 | 9375 | 0.060 |
Why?
|
| RNA, Messenger | 2 | 2017 | 13045 | 0.060 |
Why?
|
| Aortography | 1 | 2005 | 430 | 0.060 |
Why?
|
| Genetic Vectors | 1 | 2013 | 3445 | 0.060 |
Why?
|
| Spain | 1 | 2004 | 465 | 0.060 |
Why?
|
| Hypercholesterolemia | 1 | 2010 | 1141 | 0.060 |
Why?
|
| Psychiatric Status Rating Scales | 1 | 2013 | 5971 | 0.060 |
Why?
|
| Neural Conduction | 1 | 2004 | 474 | 0.060 |
Why?
|
| Solitary Nucleus | 1 | 2023 | 56 | 0.060 |
Why?
|
| Anticholesteremic Agents | 1 | 2010 | 972 | 0.060 |
Why?
|
| Prevalence | 1 | 2019 | 14951 | 0.050 |
Why?
|
| Entorhinal Cortex | 1 | 2023 | 260 | 0.050 |
Why?
|
| Severity of Illness Index | 2 | 2020 | 15454 | 0.050 |
Why?
|
| Risk Factors | 3 | 2021 | 70971 | 0.050 |
Why?
|
| Microscopy, Electron | 1 | 2004 | 2800 | 0.050 |
Why?
|
| Case-Control Studies | 3 | 2013 | 21575 | 0.050 |
Why?
|
| Age Factors | 1 | 2017 | 18337 | 0.040 |
Why?
|
| Genetic Predisposition to Disease | 2 | 2019 | 17328 | 0.040 |
Why?
|
| Ultrasonography | 1 | 2012 | 5894 | 0.040 |
Why?
|
| Oxidative Phosphorylation | 1 | 2021 | 482 | 0.040 |
Why?
|
| Algorithms | 2 | 2022 | 13759 | 0.040 |
Why?
|
| Chest Pain | 1 | 2005 | 1102 | 0.040 |
Why?
|
| Green Fluorescent Proteins | 2 | 2015 | 2121 | 0.040 |
Why?
|
| Frontotemporal Dementia | 1 | 2020 | 222 | 0.040 |
Why?
|
| Cell Proliferation | 1 | 2013 | 10472 | 0.040 |
Why?
|
| Inflammation | 2 | 2020 | 10337 | 0.040 |
Why?
|
| Cytosol | 1 | 2020 | 916 | 0.040 |
Why?
|
| Genetic Heterogeneity | 1 | 2020 | 736 | 0.040 |
Why?
|
| Protein Transport | 2 | 2012 | 2015 | 0.040 |
Why?
|
| Polymorphism, Single Nucleotide | 2 | 2013 | 15404 | 0.040 |
Why?
|
| Retrospective Studies | 2 | 2014 | 74145 | 0.030 |
Why?
|
| Natural Language Processing | 1 | 2022 | 974 | 0.030 |
Why?
|
| Dermoscopy | 1 | 2014 | 54 | 0.030 |
Why?
|
| Cell Line | 2 | 2021 | 16263 | 0.030 |
Why?
|
| Anatomy, Cross-Sectional | 1 | 2013 | 142 | 0.030 |
Why?
|
| Antibodies, Monoclonal | 1 | 2010 | 9248 | 0.030 |
Why?
|
| Spinal Cord Injuries | 1 | 2021 | 957 | 0.030 |
Why?
|
| Matched-Pair Analysis | 1 | 2013 | 292 | 0.030 |
Why?
|
| Centrifugation, Density Gradient | 1 | 2012 | 333 | 0.030 |
Why?
|
| Biopsy | 1 | 2004 | 6725 | 0.030 |
Why?
|
| Blotting, Western | 1 | 2020 | 5237 | 0.030 |
Why?
|
| Frontotemporal Lobar Degeneration | 1 | 2012 | 97 | 0.030 |
Why?
|
| Electrophoresis, Polyacrylamide Gel | 1 | 2014 | 1850 | 0.030 |
Why?
|
| Oxidative Stress | 2 | 2013 | 3094 | 0.030 |
Why?
|
| Brain Diseases | 1 | 2021 | 1525 | 0.030 |
Why?
|
| Multigene Family | 1 | 2015 | 1116 | 0.030 |
Why?
|
| Protein Binding | 2 | 2015 | 9466 | 0.030 |
Why?
|
| Protein Structure, Quaternary | 1 | 2012 | 445 | 0.020 |
Why?
|
| Microscopy, Electron, Transmission | 1 | 2013 | 732 | 0.020 |
Why?
|
| Evaluation Studies as Topic | 1 | 2013 | 1700 | 0.020 |
Why?
|
| Skin | 1 | 2004 | 4311 | 0.020 |
Why?
|
| Immunoblotting | 1 | 2014 | 1727 | 0.020 |
Why?
|
| Cells, Cultured | 2 | 2020 | 19487 | 0.020 |
Why?
|
| Sequence Deletion | 1 | 2015 | 1547 | 0.020 |
Why?
|
| Reproducibility of Results | 2 | 2022 | 19620 | 0.020 |
Why?
|
| Cerebral Cortex | 2 | 2020 | 5696 | 0.020 |
Why?
|
| Young Adult | 1 | 2017 | 55791 | 0.020 |
Why?
|
| Gene Knockdown Techniques | 1 | 2015 | 1668 | 0.020 |
Why?
|
| Amyotrophic Lateral Sclerosis | 1 | 2020 | 1389 | 0.020 |
Why?
|
| Presynaptic Terminals | 1 | 2012 | 303 | 0.020 |
Why?
|
| Fluorescent Antibody Technique | 1 | 2014 | 2571 | 0.020 |
Why?
|
| Peptide Fragments | 2 | 2012 | 5040 | 0.020 |
Why?
|
| Transgenes | 1 | 2013 | 1017 | 0.020 |
Why?
|
| Disease Models, Animal | 3 | 2013 | 18040 | 0.020 |
Why?
|
| Maze Learning | 1 | 2011 | 475 | 0.020 |
Why?
|
| Brain Injuries | 1 | 2021 | 1986 | 0.020 |
Why?
|
| Adolescent | 1 | 2017 | 84411 | 0.020 |
Why?
|
| Conditioning, Classical | 1 | 2011 | 366 | 0.020 |
Why?
|
| Paraparesis | 1 | 2007 | 13 | 0.020 |
Why?
|
| Ubiquitination | 1 | 2012 | 996 | 0.020 |
Why?
|
| Space Perception | 1 | 2011 | 471 | 0.020 |
Why?
|
| Protein Isoforms | 1 | 2012 | 1716 | 0.020 |
Why?
|
| Daunorubicin | 1 | 2007 | 150 | 0.020 |
Why?
|
| Terminology as Topic | 1 | 2014 | 1563 | 0.020 |
Why?
|
| Paresthesia | 1 | 2007 | 156 | 0.020 |
Why?
|
| Urination Disorders | 1 | 2007 | 242 | 0.020 |
Why?
|
| Electronic Health Records | 1 | 2022 | 4307 | 0.020 |
Why?
|
| Reference Values | 1 | 2013 | 4997 | 0.020 |
Why?
|
| Cytarabine | 1 | 2007 | 683 | 0.020 |
Why?
|
| Qualitative Research | 1 | 2013 | 2587 | 0.020 |
Why?
|
| Microscopy, Fluorescence | 1 | 2012 | 2785 | 0.020 |
Why?
|
| Medicare | 1 | 2022 | 6257 | 0.020 |
Why?
|
| Protein Conformation | 1 | 2012 | 4033 | 0.020 |
Why?
|
| Psychometrics | 1 | 2013 | 2949 | 0.020 |
Why?
|
| Adult | 2 | 2017 | 211523 | 0.020 |
Why?
|
| Transfection | 1 | 2012 | 5963 | 0.020 |
Why?
|
| Lipid Metabolism | 1 | 2012 | 1967 | 0.010 |
Why?
|
| Analysis of Variance | 1 | 2012 | 6396 | 0.010 |
Why?
|
| Erectile Dysfunction | 1 | 2007 | 465 | 0.010 |
Why?
|
| HEK293 Cells | 1 | 2012 | 4221 | 0.010 |
Why?
|
| Prednisone | 1 | 2007 | 1551 | 0.010 |
Why?
|
| Fear | 1 | 2011 | 1406 | 0.010 |
Why?
|
| Fatal Outcome | 1 | 2007 | 1854 | 0.010 |
Why?
|
| Remission Induction | 1 | 2007 | 2366 | 0.010 |
Why?
|
| Memory | 1 | 2011 | 2144 | 0.010 |
Why?
|
| Methotrexate | 1 | 2007 | 1707 | 0.010 |
Why?
|
| Dexamethasone | 1 | 2007 | 1940 | 0.010 |
Why?
|
| Imaging, Three-Dimensional | 1 | 2013 | 3988 | 0.010 |
Why?
|
| Action Potentials | 1 | 2007 | 1795 | 0.010 |
Why?
|
| Hydrocortisone | 1 | 2007 | 1797 | 0.010 |
Why?
|
| Sex Factors | 1 | 2013 | 10385 | 0.010 |
Why?
|
| Precursor Cell Lymphoblastic Leukemia-Lymphoma | 1 | 2007 | 1486 | 0.010 |
Why?
|
| Mice, Knockout | 1 | 2013 | 14770 | 0.010 |
Why?
|
| Gene Expression Regulation | 1 | 2015 | 12183 | 0.010 |
Why?
|
| Image Processing, Computer-Assisted | 1 | 2013 | 8909 | 0.010 |
Why?
|
| United States | 1 | 2022 | 68433 | 0.010 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 1 | 2007 | 11303 | 0.000 |
Why?
|